Xylem (NYSE:XYL) Downgraded to Hold Rating by Wall Street Zen

Xylem (NYSE:XYL) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

Several other brokerages have also recently commented on XYL. Zacks Research cut shares of Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Stifel Nicolaus lifted their price objective on Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Argus set a $170.00 target price on Xylem in a research report on Wednesday, October 29th. Weiss Ratings restated a “buy (b)” rating on shares of Xylem in a research report on Monday, December 15th. Finally, Barclays upped their price objective on shares of Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Xylem has a consensus rating of “Moderate Buy” and an average target price of $167.40.

Xylem Stock Up 0.1%

XYL opened at $138.84 on Friday. Xylem has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. The company has a market capitalization of $33.80 billion, a P/E ratio of 35.69, a P/E/G ratio of 2.15 and a beta of 1.18. The stock has a fifty day moving average of $143.20 and a 200-day moving average of $139.77.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same period last year, the firm earned $1.11 earnings per share. Xylem’s revenue for the quarter was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities analysts expect that Xylem will post 4.65 EPS for the current year.

Insider Buying and Selling

In related news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.27% of the company’s stock.

Institutional Trading of Xylem

A number of hedge funds have recently made changes to their positions in XYL. SJS Investment Consulting Inc. raised its holdings in Xylem by 1,844.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after buying an additional 166 shares during the last quarter. Knuff & Co LLC bought a new stake in Xylem during the 3rd quarter worth approximately $27,000. Wexford Capital LP acquired a new position in Xylem in the 3rd quarter valued at approximately $27,000. First Horizon Corp bought a new position in shares of Xylem during the third quarter valued at $30,000. Finally, Ramirez Asset Management Inc. lifted its holdings in shares of Xylem by 100.0% during the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.